Dr. Polina Khrizman, MD

  • Camden, NJ
  • Hematologist and oncologist
NPI1861673089PAC ID5890973556
Medicare services, 2024
942
Medicare patients, 2024
241
Part D claims, 2024
614
Publications
9
Clinical trials
6
Practice address
1 Cooper Plaza, Camden, NJ 08103
Practice phone
Call (856) 342-2000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Cooper University Hospital

Hospital · Camden, New Jersey

See all 6 affiliations

Find Dr. Khrizman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Polina Khrizman is a hematologist and oncologist in Camden, New Jersey

Dr. Khrizman practices at Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care.

Dr. Khrizman's NPI, 1861673089, was assigned on November 15, 2007. Dr. Khrizman holds New Jersey license 25MA08921200.

NPI and contact details
Medicare PAC ID
5890973556
NPI enumeration date
November 15, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(856) 342-2000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
47
Medical school graduation
2005

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Polina Khrizman practices at Cooper University Hospital in Camden, New Jersey

Dr. Khrizman's primary practice is Cooper University Hospital, at 1 Cooper Plaza, Camden, NJ 08103 in Camden County. The practice phone is (856) 342-2000.

Source: Dmand AI Affiliation Data

Dr. Polina Khrizman is affiliated with 5 sites of care and 1 medical group

Dr. Khrizman's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. Dr. Khrizman is also affiliated with Virtua Our Lady of Lourdes Hospital. The medical group on file is Cooper University Physicians. Dmand AI also links Dr. Khrizman to 2 more hospitals and 1 skilled nursing facility, each named with a free account.

See all 6 affiliations for Dr. Khrizman

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Polina Khrizman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khrizman practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Cooper University HospitalAvailable with a free account
+4 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Khrizman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Cooper University Health Care and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Polina Khrizman is one of 364 hematologists and oncologists in New Jersey

Hematology and oncology is Dr. Khrizman's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Khrizman's licenses on file in 2 states: New Jersey and Illinois.

Specialties and state licenses

  • Hematology and oncology, New JerseyPrimaryLicense 25MA08921200 · taxonomy 207RH0003X
  • Internal medicine, IllinoisLicense 125-048952 · taxonomy 207R00000X

Hematologists and oncologists near Dr. Khrizman

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Polina Khrizman billed Medicare for 942 services in 2024

CMS data shows 942 Medicare services from Dr. Khrizman across 7 procedure codes in 2024, for 241 Medicare patients. Medicare paid $52,087 for them.

Medicare services, 2024942
Medicare patients241
Paid by Medicare$52,087
Procedure codes7

Dr. Khrizman's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6572024: 54817%
Other services
2023: 02024: 394

Where Dr. Khrizman's Medicare services took place, 2024

  • In an office25527%
  • In a facility68773%

Dr. Khrizman compared with the New Jersey median for hematologists and oncologists, 2024

  • Dr. Khrizman
  • New Jersey median
Medicare services
942vs 1,51538% below
Medicare patients
241vs 33728% below
Part D claims
535vs 37842% above

Medians across 349 hematologists and oncologists in New Jersey with Dmand AI profiles that report each measure.

Dr. Khrizman's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Khrizman

Need commercial claims for Dr. Khrizman?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Khrizman and other hematologists and oncologists in New Jersey.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Polina Khrizman treated 241 Medicare patients in 2024, average age 71

CMS counts 241 Medicare patients who saw Dr. Khrizman in 2024. The largest group is 65 to 74, with 103 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khrizman's median patient age at 66, with 56% women.

Medicare patients, 2024241
Average age71
Average risk score2.53
Also on Medicaid22%

Dr. Khrizman's Medicare patients by age, 2024

Dr. Khrizman's Medicare patients by sex, 2024

  • Women12251%
  • Men11949%

Chronic conditions among Dr. Khrizman's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer63%
  4. Arthritis51%
  5. Diabetes38%
  6. Ischemic heart disease38%
  7. Anxiety37%
  8. COPD34%

Share of Medicare patients with each condition. A patient can have several.

Dr. Khrizman's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women56%
  • Men42%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Polina Khrizman wrote 614 Medicare Part D claims in 2024

In 2024, Dr. Khrizman wrote 614 Medicare Part D claims for 135 patients. 85% of them were for generic drugs. CMS names the drug for 535 of them, across 13 drugs with 11 or more claims each, at $625,909 in total drug cost. In 2023, CMS named 549 claims across 13 drugs.

Part D claims, 2024614
Drugs named by CMS13
Total drug cost$625,909
Part D patients135

Dr. Khrizman's Part D claims by kind of drug, 2024

  • Generic521 claims85%
  • Brand-name93 claims15%

Dr. Khrizman's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Khrizman's Part D claims, 2024

  • Opioids3%17 of 614 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5492024: 5353%

Drugs named by CMS: 13 in 2024, 13 in 2023.

See all prescribing by Dr. Khrizman

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Polina Khrizman scored 92 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Khrizman for performance year 2024, reported as part of a group. Dr. Khrizman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khrizman as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Khrizman's MIPS scores, performance year 2024

  • 92of 100Final score
  • 88.8of 100Quality
  • 99of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 74of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Khrizman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Polina Khrizman has 9 publications on record

Dmand AI links 9 papers to Dr. Khrizman, published from 2010 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Radiosurgery, Neoadjuvant Therapy and Rectal Neoplasms. Dr. Khrizman's most frequent co-authors are Gregory Kubicek, MD, Richard D. Lackman, MD and Wissam B. Abouzgheib, MD.

Papers9
Years published2010 to 2024

Dr. Khrizman's papers by year, 2010 to 2024

Topics Dr. Khrizman writes about most

  • Radiosurgery
  • Neoadjuvant Therapy
  • Rectal Neoplasms

Dr. Khrizman's most frequent co-authors

Recent publications by Dr. Khrizman

See all 9 publications and co-authors

See who Dr. Khrizman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Khrizman works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Polina Khrizman has worked on 6 clinical trials

Dmand AI links Dr. Khrizman to 6 clinical trials, 4 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Carcinoma, Bronchogenic and Sarcoma. National Cancer Institute (NCI) sponsors the most, 4.

Conditions in Dr. Khrizman's trials

  • Carcinoma, Non-Small-Cell Lung
  • Carcinoma, Bronchogenic
  • Sarcoma
  • Neoplasms, Connective and Soft Tissue

Investigators on the most trials with Dr. Khrizman

Recent clinical trials with Dr. Khrizman

See all 6 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Polina Khrizman received $1,768 in industry payments from 2016 to 2025

CMS Open Payments shows 81 general payments to Dr. Khrizman from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Genentech, Inc. paid the most, $288.

General payments to Dr. Khrizman by program year, 2016 to 2025

General payments to Dr. Khrizman by kind, 2016 to 2025

$1.8Kin total
  • Food and beverage$1,49284%
  • Education$27616%

Companies that paid Dr. Khrizman the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Khrizman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Polina Khrizman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Polina Khrizman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Polina Khrizman's NPI number?

Dr. Polina Khrizman's NPI number is 1861673089. It was assigned on November 15, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Polina Khrizman?

Dr. Polina Khrizman is a hematologist and oncologist in Camden, New Jersey. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Polina Khrizman practice?

Dr. Khrizman practices at 1 Cooper Plaza, Camden, NJ 08103. Dr. Khrizman's primary practice is Cooper University Hospital in Camden, New Jersey, part of Cooper University Health Care. Dmand AI also links Dr. Khrizman to 2 hospitals and 1 skilled nursing facility.

What is Dr. Polina Khrizman's office phone number?

The practice phone on file for Dr. Khrizman is (856) 342-2000.

What is Dr. Polina Khrizman's medical license number?

Dr. Khrizman holds New Jersey license 25MA08921200, one of the licenses on file in 2 states.

Which states has Dr. Polina Khrizman been licensed in?

Dmand AI has state licenses on file for Dr. Khrizman in New Jersey and Illinois.

Which hospitals is Dr. Polina Khrizman affiliated with?

Dr. Khrizman practices at Cooper University Hospital in Camden, New Jersey. Dr. Khrizman is also affiliated with Virtua Our Lady of Lourdes Hospital. Dmand AI links Dr. Khrizman to 2 more hospitals.

What medical group is Dr. Polina Khrizman part of?

Dr. Khrizman is linked to Cooper University Physicians.

Does Dr. Polina Khrizman accept Medicare?

Yes. CMS data shows Dr. Khrizman billed Medicare for 942 services in 2024, and Dr. Khrizman accepts Medicare assignment.

Does Dr. Polina Khrizman offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Khrizman as offering telehealth services.

Show 8 more questionsShow fewer questions

What is Dr. Polina Khrizman's MIPS score?

Dr. Khrizman's MIPS final score for performance year 2024 is 92 out of 100, reported as part of a group.

How many Medicare patients does Dr. Polina Khrizman see?

CMS counts 241 Medicare patients who saw Dr. Khrizman in 2024, with an average age of 71.

What services does Dr. Polina Khrizman bill to Medicare?

In 2024, Dr. Khrizman's most billed Medicare services were medicare service (G2211), office visit, established patient (99213) and office visit, established patient (99215).

What drugs does Dr. Polina Khrizman prescribe most?

In 2024 Medicare Part D data, Dr. Khrizman's most prescribed drugs by claims were Prochlorperazine Maleate, Ondansetron ODT and Dexamethasone.

Has Dr. Polina Khrizman received payments from drug or device companies?

CMS Open Payments shows $1,768 in general payments to Dr. Khrizman from 23 companies from 2016 to 2025. The largest total came from Genentech, Inc.

How long has Dr. Polina Khrizman been practicing?

Dr. Khrizman graduated from medical school in 2005, 21 years ago.

Does Dr. Polina Khrizman do research?

Dmand AI links 9 publications to Dr. Khrizman, published from 2010 to 2024. Dr. Khrizman has worked on 6 clinical trials.

Who does Dr. Polina Khrizman publish with?

Dr. Khrizman's most frequent co-authors are Gregory Kubicek, MD (3 shared papers), Richard D. Lackman, MD (2 shared papers) and Wissam B. Abouzgheib, MD (1 shared paper).

Selling to hematology and oncology practices?

See hematologists and oncologists in New Jersey by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)